Lawal Sodiq Kolawole, Olojede Samuel Oluwaseun, Alabi Babatunde Adebola, Dithole Kafalotse Sylvia, Matula Samuel Thopho, Naidu Edwin Coleridge, Rennie Carmen Olivia, Azu Onyemaechi Okpara
School of Nursing, Faculty of Health Sciences, University of Botswana, Private Bag UB 0022, Plot 4775, Notwane Road, Gaborone, Botswana.
Discipline of Clinical Anatomy, School of Laboratory Medicine & Medical Sciences, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban 3629, South Africa.
Pharmaceuticals (Basel). 2024 Dec 5;17(12):1635. doi: 10.3390/ph17121635.
Adverse complications like metabolic disorders, neurotoxicity, and low central nervous system (CNS) penetration are associated with the long-term use of tenofovir disoproxil fumarate (TDF). Therefore, some modifications are required to enhance neurological functions using silver nanoparticles (AgNPs). This study aimed to evaluate the neuroprotective impact of silver nanoparticles (AgNPs)-conjugated TDF as AgNPs-TDF on the hippocampal microanatomy and some neuro-biomarkers of diabetic rats. Forty-two male Sprague-Dawley rats, with an average weight of 250 ± 13 g, were divided into non-diabetic and diabetic groups. They were further divided into 3 groups each (n = 7): non-diabetic control (NC), non-diabetic + TDF (NTF), and non-diabetic + TDF + silver nanoparticles (NTS), as well as diabetic control (DC), diabetic + TDF (DTF), and diabetic + TDF + silver nanoparticles (DTS). The characterization of AgNPs-TDF was assessed, and the conjugates were administered to the diabetic rats, followed by behavioral testing and biochemical, immunohistochemical, and microanatomy analyses of the hippocampus. The results showed that the administration of AgNPs-TDF significantly reduced the blood glucose level, malondialdehyde (MDA), and inflammatory biomarker concentrations in DTS compared with the DTF and DC groups. Furthermore, AgNPs-TDF administration significantly increased the levels of tissue superoxide dismutase (SOD), reduced glutathione (GSH), and insulin-like growth factor-1 in DTS compared with the DTF and DC groups. In addition, the DTS group revealed a monomorphic pattern of dark-stained neuronal nuclei similar to the control group and showed neuroprotective effects on hippocampal microanatomy compared with the DTF group. This study shows that AgNPs-TDF restores various alterations in the hippocampus and improves cognitive functions in diabetic rats.
诸如代谢紊乱、神经毒性以及中枢神经系统(CNS)渗透性低等不良并发症与长期使用富马酸替诺福韦二吡呋酯(TDF)有关。因此,需要进行一些改进,利用银纳米颗粒(AgNPs)来增强神经功能。本研究旨在评估银纳米颗粒(AgNPs)偶联TDF即AgNPs - TDF对糖尿病大鼠海马体微观解剖结构和一些神经生物标志物的神经保护作用。42只平均体重为250±13克的雄性Sprague - Dawley大鼠被分为非糖尿病组和糖尿病组。它们又进一步各自分为3组(每组n = 7):非糖尿病对照组(NC)、非糖尿病 + TDF组(NTF)、非糖尿病 + TDF + 银纳米颗粒组(NTS),以及糖尿病对照组(DC)、糖尿病 + TDF组(DTF)、糖尿病 + TDF + 银纳米颗粒组(DTS)。对AgNPs - TDF进行了表征评估,并将偶联物给予糖尿病大鼠,随后进行行为测试以及对海马体进行生化、免疫组织化学和微观解剖分析。结果显示,与DTF组和DC组相比,给予AgNPs - TDF显著降低了DTS组的血糖水平、丙二醛(MDA)和炎症生物标志物浓度。此外,与DTF组和DC组相比,给予AgNPs - TDF显著提高了DTS组的组织超氧化物歧化酶(SOD)、还原型谷胱甘肽(GSH)和胰岛素样生长因子 - 1水平。另外,DTS组显示出与对照组相似的深色神经元细胞核单态模式,并且与DTF组相比,对海马体微观解剖结构具有神经保护作用。本研究表明,AgNPs - TDF可恢复糖尿病大鼠海马体的各种改变并改善其认知功能。